Pembrolizumab 25mg/mL; per vial; soln for IV infusion after dilution; preservative-free.
Disease: Cancer, bladder
Mitomycin 40mg/vial; lyophilized pwd for pyelocalyceal soln after reconstitution; contains mannitol.
Enfortumab vedotin-ejfv 20mg, 30mg; per vial; lyophilized pwd for IV infusion after reconstitution and dilution; preservative-free.
Erdafitinib 3mg, 4mg, 5mg; tabs.
Thiotepa 15mg, 100mg; per vial; lyophilized pwd for IV, intravesical, or intracavitary administration after reconstitution and dilution.
Avelumab 20mg/mL; soln for IV infusion after dilution; preservative-free; contains mannitol.
Atezolizumab 60mg/mL; soln for IV infusion after dilution; preservative-free.
Doxorubicin HCl 2mg/mL; soln for IV inj.
Doxorubicin HCl 10mg/vial, 20mg/vial, 50mg/vial; pwd for IV inj after reconstitution; contains lactose.
Valrubicin 40mg/mL; soln for intravesical instillation after dilution; contains 50% polyoxyl castor oil/50% dehydrated alcohol; preservative-free.